How a poorly explored immune cell may impact cancer immunity and immunotherapy

Posted by on November 17, 2017 6:18 pm
Categories: Top News

The immune cells that are trained to fight off the body’s invaders can become defective. It’s what allows cancer to develop. So most research has targeted these co-called effector T-cells. But a new study takes a step back and considers: What if the problem isn’t with the effector T-cells but starts higher up the cellular chain?

Leave a Reply

Your email address will not be published. Required fields are marked *